Berylson Capital Partners’s Ascendis Pharma A/S ASND Stock Holding History

Berylson Capital Partners’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$284K	Hold	1,900	–	–	0.69%	20
2024 Q2	$259K	Sell	1,900 -700	-27%	-$95.2K	0.66%	19
2024 Q1	$393K	Hold	2,600	–	–	0.79%	23
2023 Q4	$327K	Hold	2,600	–	–	0.61%	25
2023 Q3	$243K	Hold	2,600	–	–	0.62%	25
2023 Q2	$232K	Sell	2,600 -11,000	-81%	-$957K	0.66%	20
2023 Q1	$1.46M	Buy	+13,600	New	+$1.56M	3.67%	16
2022 Q4	–	Sell	-51,000	Closed	-$5.27M	–	20
2022 Q3	$5.27M	Buy	+51,000	New	+$4.84M	8.7%	1
2022 Q2	–	Sell	-39,400	Closed	-$4.62M	–	22
2022 Q1	$4.62M	Buy	+39,400	New	+$4.56M	5.42%	4
2021 Q3	–	Sell	-70,300	Closed	-$9.25M	–	29
2021 Q2	$9.25M	Sell	70,300 -22,025	-24%	-$2.93M	2.05%	23
2021 Q1	$11.9M	Buy	92,325 +19,625	+27%	+$2.98M	2.9%	13
2020 Q4	$12.1M	Hold	72,700	–	–	2.07%	15
2020 Q3	$11.2M	Buy	72,700 +14,500	+25%	+$2.08M	3.93%	6
2020 Q2	$8.61M	Buy	+58,200	New	+$7.99M	5.29%	7
2019 Q2	–	Sell	-8,300	Closed	-$977K	–	23
2019 Q1	$977K	Buy	+8,300	New	+$727K	1.16%	29

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Berylson Capital Partners's ASND Position: Q3 2024 in Review

Berylson Capital Partners held its Ascendis Pharma A/S (ASND) position steady in Q3 2024 at 1,900 shares worth $284K. The position accounts for 0.69% of the portfolio, ranked #20.

Berylson Capital Partners first reported a position in ASND in Q1 2019 and has held it in 15 quarters since. The position peaked at $12.1M in Q4 2020. 219 funds tracked by Wall St. Rank hold ASND as of Q3 2024.

Berylson Capital Partners held 1,900 shares of Ascendis Pharma A/S worth $284K as of Q3 2024.
Berylson Capital Partners left its Ascendis Pharma A/S share count unchanged in Q3 2024.
Ascendis Pharma A/S made up 0.69% of Berylson Capital Partners's portfolio in Q3 2024, its #20 holding.
Berylson Capital Partners first reported a position in Ascendis Pharma A/S in Q1 2019 and has held it in 15 quarters since.
Berylson Capital Partners's Ascendis Pharma A/S position peaked at $12.1M in Q4 2020.
219 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2024.

Based on Berylson Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.